Erratum to atractylodin may induce ferroptosis of human hepatocellular carcinoma cells
Erratum to: Ann Transl Med 2021;9:1535
This article (1) titled “Atractylodin may induce ferroptosis of human hepatocellular carcinoma cells” (doi: 10.21037/atm-21-4386), unfortunately contains errors in Figure 3 and the Reagents and Antibodies section of the main text.
The pictures of Figure 3A and 3C overlapped and should be corrected. The corrected Figure 3 is presented below.
Corrected Figure 3:
In the Reagents and Antibodies section, part of the first sentence should be changed from “Atractylin (C13H10O), purity ≥99%, relative molecular weight: GPX4 polyclonal antibody (#14432-1-AP), ACSL4 monoclonal antibody (#666171-IG), CD71, GPX4 polyclonal antibody (#14432-1-AP)” to “Atractylotin (C13H10O), purity ≥99%, GPX4 polyclonal antibody (#14432-1-AP), Beta Actin Recombinant antibody (#81115-1-RR)”.
The authors apologize for the oversight.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- He Y, Fang D, Liang T, et al. Atractylodin may induce ferroptosis of human hepatocellular carcinoma cells. Ann Transl Med 2021;9:1535. [Crossref] [PubMed]
